Seven Mile Advisory Buys 90 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Seven Mile Advisory raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,726 shares of the healthcare conglomerate’s stock after purchasing an additional 90 shares during the quarter. Seven Mile Advisory’s holdings in UnitedHealth Group were worth $879,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vista Capital Partners Inc. grew its position in UnitedHealth Group by 5.3% in the second quarter. Vista Capital Partners Inc. now owns 639 shares of the healthcare conglomerate’s stock valued at $325,000 after purchasing an additional 32 shares in the last quarter. Lyell Wealth Management LP increased its position in shares of UnitedHealth Group by 13.0% in the second quarter. Lyell Wealth Management LP now owns 8,556 shares of the healthcare conglomerate’s stock valued at $4,357,000 after acquiring an additional 985 shares during the last quarter. J.W. Cole Advisors Inc. grew its stake in UnitedHealth Group by 70.3% in the second quarter. J.W. Cole Advisors Inc. now owns 8,893 shares of the healthcare conglomerate’s stock valued at $4,529,000 after purchasing an additional 3,672 shares in the last quarter. Chronos Wealth Management LLC raised its stake in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Chronos Wealth Management LLC now owns 17,463 shares of the healthcare conglomerate’s stock worth $8,893,000 after purchasing an additional 424 shares in the last quarter. Finally, OV Management LLC increased its holdings in UnitedHealth Group by 1.6% during the second quarter. OV Management LLC now owns 2,844 shares of the healthcare conglomerate’s stock worth $1,448,000 after buying an additional 44 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Up 1.0 %

UNH stock opened at $594.32 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The company has a market cap of $548.81 billion, a PE ratio of 36.33, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The business has a 50-day simple moving average of $569.08 and a 200 day simple moving average of $517.57.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period last year, the firm posted $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. UBS Group lifted their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Truist Financial upped their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Argus lifted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.